IBL Healthcare Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: PK0095501018
PKR
55.95
0.03 (0.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About IBL Healthcare Ltd. stock-summary
stock-summary
IBL Healthcare Ltd.
Retailing
IBL HealthCare Limited is a Pakistan-based company engaged in marketing, selling and distribution of healthcare products. The Company is engaged in providing a range of healthcare and nutritional products. The Company's divisions include Mead Johnson Nutrition, Nestle Health Science, Brand Plus, Medical Disposable Division and Principle Health Care. The Mead Johnson Nutrition division offers approximately 70 products, such as Enfamama A+, Enfamil A+ Stage 1, Enfamil A+ Stage 2, Enfagrow A+ Stage 3 and Sustagen school 6+. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the challenges of different life stages. It offers products, such as Resource Diabetes and Resource Optimum. The Brand Plus division provides a range of baby cereals. The Medical Disposable division consist a range of medical disposables. The Principle Health Care division is a vitamin, mineral and food supplement producer.
Company Coordinates stock-summary
Company Details
9th Floor, N.I.C. Building, Abbasi Shaheed Road KARACHI None : 75530
stock-summary
Tel: 92 21 37170200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Rashid Abdulla
Non-Executive Chairman of the Board
Mr. Mufti Ziaul ul Islam
Chief Executive Officer, Executive Director
Mr. Shahid Abdulla
Director
Mr. Arshad Anis
Director
Mr. Ayaz Abdulla
Non-Executive Director
Mr. Syed Ahmed
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
948 Million
(Quarterly Results - Mar 2025)
Net Profit:
35 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

PKR 6,579 Million (Small Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

9.12%

stock-summary
Price to Book

2.75